Viewing StudyNCT05765773



Ignite Creation Date: 2024-05-06 @ 6:44 PM
Last Modification Date: 2024-10-26 @ 2:53 PM
Study NCT ID: NCT05765773
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-03-13
First Post: 2023-02-13

Brief Title: An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine CoviVac for Adults Aged 60 Years and Older
Sponsor: Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
Organization: Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-07-01
Start Date Type: ACTUAL
Primary Completion Date: 2022-10-01
Primary Completion Date Type: ACTUAL
Completion Date: 2023-03-01
Completion Date Type: ESTIMATED
First Submit Date: 2023-02-13
First Submit QC Date: March 9 2023
Study First Post Date: 2023-03-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-03-09
Last Update Post Date: 2023-03-13
Last Update Post Date Type: ACTUAL